baber/WOPTO huggingface dataset:
Patent NZ-527470-A (NZ)
Title: Acylated indanyl amines and their use as pharmaceuticals
Inventor: STROBEL HARTMUT
IPC: C07D271/08
Filed: 2002-02-12
Abstract: Disclosed are acylated indanyl amine compounds of formula (I), wherein: A is CH2, CHOH or CH-alkyl, B is CH2 or CH-alkyl, R5 is Ar or hetar, which may be optionally substituted, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the stimulation of endothelial NO-synthase.
Patent NZ-531442-A (NZ)
Title: Supplying solid feed materials for a direct smelting process
Inventor: LEIGH DAVID JOHN
IPC: F27D3/18
Filed: 2002-10-09
Abstract: A process and apparatus for supplying solid feed materials for a direct smelting process to solids injection lances of a direct smelting vessel is disclosed. The feed materials supply apparatus includes a supply line (L) for conveying iron-containing material and solid carbonaceous material under pressure to solids injection lances (7), and the supply line includes a main feeder line section (15) and a plurality of branch line sections (17) extending from the main feeder line section. Each branch line section is connected to one solids injection lance for supplying iron-containing material and carbonaceous material to that lance. The apparatus further includes an assembly for dispensing iron-containing material under pressure into the main feeder line section of the supply line and an assembly for dispensing carbonaceous material under pressure into the main feeder line section of the supply line.
Patent NZ-534092-A (NZ)
Title: Computer generated interactive environment with characters for learning a language
Inventor: HARDING STEVEN JAMES
Filed: 2004-07-12
Abstract: A computer-implemented method of language learning includes displaying on a user display an environment representative of a real world environment such as an airport terminal where a user can navigate a character representation (3) around the environment. The environment also contains a plurality of destination points (2A, 2B, 2C) for the character. At selected destination points either exemplar or interactive conversations (7, 8) are initiated with the character. The user can select a conversation or part of a conversation to be communicated in a language being learnt by the user or in a language already known by the user.
Patent NZ-540496-A (NZ)
Title: Prevention and treatment of alzheimer's disease
Inventor: CANTON THIERRY
IPC: A61K45/06
Filed: 2003-12-10
Abstract: The use of biliary acid intestinal recapture inhibitors for preventing and treating Alzheimer's disease, optionally combined with a HMG-CoA reductase inhibitor, a cholesterol capture inhibitor, a cholesterol synthesis capture inhibitor or an APP secretase inhibitor.
Patent NZ-540697-A (NZ)
Title: Formable and settable polymer bone composite and method of production thereof
Inventor: WINTERBOTTOM JOHN M
IPC: A61L27/36
Filed: 2003-12-12
Abstract: Disclosed is a composite osteoimplant, comprising: a polymer; and bone-derived particles, wherein the composite is adapted and constructed to be formable during implantation or immediately prior to implantation and to be set under predetermined conditions preferably after final surgical placement.
Patent NZ-540815-A (NZ)
Title: Process for preparing optically pure active compounds
Inventor: KOHL BERNHARD
IPC: C07D401/12
Filed: 2003-12-03
Abstract: Disclosed is a process for preparing an optically pure Proton Pump Inhibitor (PPI) having a specified sulphinyl structure using a chiral zirconium complex or a chiral hafnium complex wherein the chiral zirconium complex or chiral hafnium complex includes a chiral auxiliary.
Patent NZ-543462-A (NZ)
Title: Bleach odor reducing chlorine bleach composition
Inventor: MERCADO HEDELIZA MALONZO
IPC: C11D3/395
Filed: 2004-05-18
Abstract: Disclosed is a hypochlorite containing composition comprising by weight: (a) 0.1% to 10% of a chlorine bleach compound; (b) 0.0001% to 5% of a bleach odour reducing agent, which is ethyl tricyclo[5.2.1.12.6]decan-2-carboxylate (fruitate). (c) 0.05% to 3% of an alkali metal hydroxide; (d) 0.2% to 5% of an alkali metal carbonate; (f) 0.1% to 3% of an alkali metal silicate which can act both as a buffer and a corrosion inhibitor; (g) 0.25% to 5% of a phosphate builder salt; and (h) the balance being water, wherein the composition has a pH of 9 to 14.
Patent NZ-545500-A (NZ)
Title: Hydrogenolysis of sugar feedstock
Inventor: CRABTREE SIMON PETER
IPC: C07C29/00
Filed: 2004-10-15
Abstract: A process for the hydrogenolysis of a sugar feedstock comprising one or more of polyols, alditols, aldoses and polymers of aldoses is disclosed, wherein said hydrogenolysis is carried out in the presence of a catalyst comprising: (a) ruthenium or osmium; and (b) an organic phosphine; and wherein the hydrogenolysis is carried out in the presence of water and at a temperature of greater than 150 Deg. C to 260 Deg. C.
Patent NZ-554368-A (NZ)
Title: Methods for making improved texture cereal bars
Inventor: COLEMAN EDWARD C
IPC: A23L7/196
Filed: 2007-04-05
Abstract: Disclosed is a method for making cereal bars, comprising, forming a cereal matrix comprising cereal pieces and an edible binder in a wt:wt ratio of about 2:1 to about 1:2, respectively, into a cereal matrix layer having an exposed external portion and an internal central portion, wherein the external portion and internal portion each has an initial water activity exceeding about 0.35; heating the cereal matrix layer for a time and temperature effective to reduce water activity to less than about 0.3 in the external portion of the of the cereal matrix layer, while maintaining the internal central portion of the cereal matrix layer at a water activity greater than about 0.40, to provide a heated layer; cooling the heated layer to provide a cooled layer; cutting the cooled layer, or alternatively the cereal matrix layer prior to the heating step, effective to form discrete cereal bars; and allowing moisture content of the discrete cereal bars to equilibrate such that each of the external surface portion and the interior central portion each has a water activity of about 0.35 to about 0.6.
Patent NZ-554390-A (NZ)
Title: Osteoprotegerin variant proteins
Inventor: ROBERTS ANTHONY
IPC: C07K14/715
Filed: 2005-12-13
Abstract: Provided is an ostooprotegerin (OPG) variant protein comprising at least one amino acid residue that differs from wild-type OPG, wherein the at least one amino acid is in the region encompassed by amino acid residues 102-130, and wherein the OPG variant protein retains binding affinity for receptor activator of NFkB ligand (RANKL) but exhibits a binding affinity for TNF-related apoptosis inducing ligand (TRAIL) which is less than 50% that of wild-type OPG. The compositions are useful for the treatment of cardiovascular diseases and bone diseases.
Patent NZ-571668-A (NZ)
Title: Water management system using controlled valves each with pressure and flow sensors and a water bypass
Inventor: PICTON DAVID JOHN
IPC: E03B7/04
Filed: 2008-09-30
Abstract: A water management system is disclosed. The system will have at least one electrically operated valve located in a supply line. Each valve has an inlet and an outlet to a zone controlled by that valve, the zone having one or more points of use such as a sink, dishwasher or hot water heater. Each valve has a shut-off valve member and a metering valve member, the metering valve member having a small bypass passageway to enable a very small water flow to bypass the metering valve member when the metering valve is in its fully closed position. Each valve also is capable of allowing a number of different flow rates from a fully shut off position to fully open position including also a sensing position with a minimal flow rate. A pressure sensor is located in the valve or downstream of the valve outlet to detect pressure of the water in the zone supplied by the valve. A flow sensor is located in the valve or downstream of the valve outlet to measure the flow rate of water flowing in the zone supplied by the valve. A controller interfaced to each pressure sensor, each flow sensor and each electrically operated water valve. The controller being is able to terminate or change the flow of water to a zone or point of use in the event that the flow rate exceeds a maximum allowed value, or the total flow exceeds a maximum allowed quota, or a pressure change is detected in the line.
Patent NZ-572402-A (NZ)
Title: Access control device
Inventor: POLLABAUER REINHARD
IPC: B60R25/00
Filed: 2007-03-22
Abstract: Disclosed is an access control device including a lock with a locking element, an actuating element for the locking element, an electronic key, an electrical circuit including a receiver unit for receiving key identification data and an evaluation circuit for determining access authorization based on the received identification data, said evaluation circuit cooperating with the actuating element and/or the locking element for selectively locking or unlocking the lock, wherein the electronic key comprises means for generating a capacitive near field via which the identification data is emitted, and a device for coupling the capacitive near field to a person carrying the key, and that the receiver unit of the lock comprises at least one capacitive coupling surface such that an alternating current circuit closes at a contact of the lock, or an approach of the lock, by said person and an electric flux is created across the lock, which can be detected by the receiver unit.
Patent NZ-574141-A (NZ)
Title: System for and method of audio signal processing for presentation in a high-noise environment
Inventor: BONGIOVI ANTHONY
IPC: H03G5/00
Filed: 2005-08-01
Abstract: A method for hard-programming adjustments into at least one multi-band equalizer that compensates for anomalies associated with an anticipated listening environment is disclosed. A test signal is presented into the anticipated listening environment and audio presentation anomalies associated with the anticipated listening environment from responses from the test signal are detected. The frequency associated with the anomalies of the test signal is determined and the amplitude at the frequency to compensate for the anomalies in the multi-band equalizer is adjusted. The adjustments at the frequencies are hard-programmed into at least one multiband equalizer. An audio signal is primary equalized by adjusting an amplitude of a low frequency portion of the audio signal and adjusting in an opposite direction an amplitude of a high frequency portion of the audio signal. The adjusting and the adjusting in the opposite direction intersect between a frequency range produces a substantially negligible gain. A dynamic range of the audio signal is compresses and the audio signal is mirror equalized in a substantially opposite way as the primary equalizing; and then an amplitude of the audio signal is adjusted with the at least one multi-band equalizer. (62) Divided Out of 553744
Patent NZ-582446-A (NZ)
Title: Paper making compositions and processes using protein particulate, colloidal pigment, and latex polymer combinations
Inventor: DYKSTRA GERALD M
IPC: D21H19/56
Filed: 2008-07-10
Abstract: Disclosed is a composition for treating paper products comprising protein particulate (preferably comprising of dry comminuted defatted legume seeds selected from soy beans and other beans, peas, and peanuts), colloidal pigment (preferably comprising of calcium carbonate, calcined kaolin, hydrous kaolin, China clay, talc, mica, dolomite, silica, silicate, zeolite, gypsum, satin white, titania, titanium dioxide, calcium sulfate, barium sulfate, aluminium trihydrate, lithopone, blanc fixe, plastic pigment, or combinations thereof), synthetic latex polymer (preferably comprising of styrene butadiene copolymer, carboxyl styrene-butadiene copolymer, styrene acrylate, styrene acrylonitrile, vinyl acrylate, acrylic, polyvinyl acetate, vinyl polyacetate, carboxyl vinyl polyacetate, alkyl acrylate-vinyl acetate copolymer, or carboxyl alkyl acrylate-vinyl acetate copolymer, or combinations thereof), and preservative (preferably selected from isothiazoline, propyl 4-hydroxybenzoate, butylated hydroxyanisole, or combinations thereof), wherein the composition is an aqueous dispersion containing from about 8 weight % to about 12 weight % total solids.
Patent NZ-583063-A (NZ)
Title: Reducing time offsets in wireless communications by slowing updating of precoding settings
Inventor: HUI DENNIS
IPC: H04L5/00
Filed: 2008-08-20
Abstract: Disclosed is a base station (10) configured to reduce temporal variations in interference caused by its transmissions. The base station (10) is comprised of transmission circuits (18) configured to transmit data to a plurality of mobile stations (12) and one or more processing circuits (16). The transmission circuits (18) transmit data via an Orthogonal Frequency Division Multiplex (OFDM) signal comprising a plurality of subcarriers. The subcarriers are transmitted from two or more transmit antennas (14) according to a fixed number of linear precoding weight sets. The processing circuits (16) are configured to form subcarrier sets by assigning each subcarrier to one of the linear precoding weight sets. The processing circuits (16) also assign each mobile station (12) to one of the subcarrier sets and restrict changes to the subcarrier sets to superframe interval boundaries. A superframe interval is defined to be at least several multiples of a channel quality measurement cycle time associated with the mobile stations (12).
Patent NZ-586766-A (NZ)
Title: Separate patient monitoring system interfaced with drug delivery system
Inventor: KATZ HAL H
IPC: G16H20/17
Filed: 2004-03-03
Abstract: A patient monitoring system useful over the full duration of a medical procedure includes a compact and portable microprocessor based patient unit 10 with a first series of connection points 26 to 34 for receiving input signals from patient monitoring connections, a second series of connection points for outputting patient parameters, a patient parameter memory store, and a patient parameter display screen. The system also includes a microprocessor based procedure unit 12 that is used during a medical procedure for receiving patient parameters from the patient unit and for controlling drug delivery to the patient. The procedure unit also has a display screen to display the patient parameters. The system includes a communication cable 14 for communicating the patient parameters from the patient unit to the procedure unit. The patient unit functions whilst independent of or connected to the procedure unit, and when the patient unit is connected to the procedure unit, the history of at least one of the patient parameters is transferred from the patient unit to the procedure unit. The system offers advantages of not having to disconnect and reconnect monitoring units whilst transferring the patient between the preparation room and the procedure theatre.
Patent NZ-587187-A (NZ)
Title: Compositions Comprising Actinidia ( Kiwifruit) and a Steriod Methods of Use Thereof in Manufacture of Medicament
Inventor: BRAMAN MARK A
IPC: A61P17/00
Filed: 2006-02-24
Abstract: Discloses the use of a kiwifruit preparation or extract and at least one steroid in the manufacture of a composition for treatment of a disease or condition wherein the disease or condition comprises an allergic disease or a non-allergic inflammatory disease. The kiwifruit may be selected from the group consisting of Actinidia arguta, Actinidia kolomikta and Actinidia polygama.
Patent NZ-589300-A (NZ)
Title: Detection of cannabis use using an antibody to detect the immune complex between THC and an anti-THC antibody
Inventor: TAKKINEN KRISTIINA
IPC: G01N33/68
Filed: 2009-06-05
Abstract: Provided is an antibody capable of binding an immune complex between tetrahydrocannabinol (THC) and an anti-THC-antibody. The antibody can be used for screening people for presence of cannabinoids.
Patent NZ-594258-A (NZ)
Title: Shared media content list
Inventor: FARRELL DOMINIC
IPC: H04N7/173
Filed: 2010-01-25
Abstract: 594258 Disclosed is a method of displaying a listing of media content stored on a plurality of media devices in a local area network (1). Access is requested by a first media device (3a) to media content stored on a second media device (3b, 3c) via the local area network (1) such that the media content is associated with at least one access criterion. For each stored media content, it is determined if the first media device (3a) meets the associated at least one access criterion. The first media device (3a) then displays an agglomerated listing of the media content stored on the first (3a) and second (3b, 3c) media devices which are determined to have associated at least one access criterion met by the first media device (3a).
Patent NZ-595627-A (NZ)
Title: Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators
Inventor: KUHNERT SVEN
IPC: A61K31/44
Filed: 2010-03-11
Abstract: The invention relates to substituted 2-mercapto-3-aminopyridines of Formula (1), methods for the production thereof, medicaments containing said compounds, and the use of said compounds for producing medicaments suitable for treating pain, epilepsy, urinary incontinence, anxiety states, dependency, mania, bipolar disorders, migraine, cognitive diseases, dystonia-associated dyskinesias and/or urinary incontinence. Examples of such compounds are: 4-Fluoro-2-hydroxy-N-[2-[2-[[3-(trifluoromethyl)phenyl]sulfonyl]-ethylsulfanyl]-pyridin-3-yl] benzamide; N-[2-[2-[[3-(Trifluoromethyl)phenyl]sulfonyl]-ethylsulfanyl]-pyridin-3-yl]-tetrahydropyrane-2-carboxylic acid amide; 3-Hydroxy-N-[2-[2-[[3-(trifluoromethyl)phenyl]sulfonyl]-ethylsulfanyl]-pyridin-3-yl] benzamide; N-[2-[2-[[3-(Trifluoromethyl)phenyl]sulfonyl]-ethylsulfanyl]-pyridin-3-yl]-thiophene-2-carboxylic acid amide; N-[2-[2-(Benzenesulfonyl)-ethylsulfanyl]-pyridin-3-yl]-2-cyclohexyl acetamide.
Patent NZ-597054-A (NZ)
Title: Herbicidal concentrate compositions containing glyphosate and dicamba salts
Inventor: ZHANG HONG
IPC: A01N25/02
Filed: 2010-06-24
Abstract: Disclosed herein is a homogeneous, stable, high-strength aqueous herbicidal concentrate composition comprising: (a) water, (b) a glyphosate potassium or amine salt, preferably a monoethanolamine, dimethylethanolamine, dimethylamine, diglycolamine or choline salt, and (c) a dicamba potassium or amine salt, such as dimethyl amine , monoethanolamine, dimethylethanolamine, choline or diglycolamine salt, in which (i) the glyphosate salt is potassium or a secondary, tertiary or quaternary alkylamine or a primary, secondary, tertiary or quaternary alkanolamine, alkylalkanolamine or alkoxyalkanolamine salt, wherein the alkyl and alkanol groups are saturated and contain from Cr C4 carbon atoms individually, (ii) the dicamba salt is potassium or a secondary, tertiary or quaternary alkylamine or a primary, secondary, tertiary or quaternary alkanolamine, alkylalkanolamine or alkoxyalkanolamine salt, wherein the alkyl and alkanol groups are saturated and contain from C1-C4 carbon atoms individually, (iii) the composition contains a total active ingredient loading of at least 300 gae/L of the glyphosate potassium or amine salt and the dicamba potassium or amine salt, (iv) the acid equivalent weight ratio of the glyphosate potassium or amine salt to the dicamba potassium or amine salt is from 1:1 to 3:1, and (v) the pH is from 6.0 to 8.0. Optionally further comprising a least one cosolvent in amounts between 20 g/L and 200 g/l, ate least one efficacy enhancing surfactant in amounts between 20 g/L and 200 g/L, and a second auxin type herbicide including chlorophenoxy acids such as 2,4-dichlorophenoxy acetic acid [2,4-D], 2,4-dichlorophenoxy butyric acid [2,4-DB], (4-chloro-2-methylphenoxy)acetic acid [MCPA] or 4-(4-chloro-2- methylphenoxy)butanoic acid [MCPB]; pyridine carboxylic acids such as picloram, aminopyralid, fluroxypyr, clopyralid or triclopyr; or quinoline carboxylic acids such as quinmerac or quinclorac.
Patent NZ-599605-A (NZ)
Title: Hemostatic compositions and therapeutic regimens
Inventor: FINKIELSZTEIN SERGIO
IPC: A61K9/70
Filed: 2008-02-19
Abstract: 599605 Disclosed is the use of a composition comprising biocompatible poly-?-1(4-N-acetylglucosamine in the manufacture of a medicament for treating a chronic wound in a human subject by repeated topical application of the composition every 5 to 18 days to a chronic wound in a human subject in need thereof.
Patent NZ-602762-A (NZ)
Title: Wire connection and distribution casing with connecting part, hollow pipe columns and connected part for communication cables
Inventor: HSING CHIH-KUANG
IPC: H02G15/10
Filed: 2010-03-03
Abstract: A wire connection and distribution casing (1) is disclosed. The casing has a connecting part, hollow pipe columns and a connected part for communication cables includes at least one cable inlet and outlet end face (2) and at least one connected part (8). At least one connecting part (3) and at least one hollow pipe column (801 Fig 2d) is provided for the communication cables (502) penetrating through the cable inlet and outlet end face (2) and entering into the wire connection and distribution casing (1). The communication cables (502) that penetrate through the hollow pipe columns (801 Fig 2d) form waterproof structures by means of elastic shrinkable pipes. The connected part (8) and the communication cables (502) which are to penetrate through the connecting part (3) and enter into the wire connection and distribution casing (1) for the communication cables form a waterproof structure including elastic shrinkable pipes. The connected part (8) may form a waterproof structure by combining with the connecting part (3).
Patent NZ-605980-A (NZ)
Title: Anti-fap antibodies and methods of use
Inventor: FREIMOSER-GRUNDSCHOBER ANNE
IPC: C07K16/18
Filed: 2011-08-09
Abstract: Disclosed is an antibody that specifically binds to Fibroblast Activation Protein (FAP), wherein said antibody comprises: -a heavy chain variable region comprising (a) a heavy chain CDR1 selected from the group of SEQ ID NO: 3, SEQ ID NO: 13, and SEQ ID NO: 23; (b) a heavy chain CDR2 selected from the group SEQ ID NO: 47, SEQ ID NO: 81, and SEQ ID NO: 113; and (c) the heavy chain CDR3 of SEQ ID NO: 135; -and a light chain variable region comprising (a) the light chain CDR1 of SEQ ID NO: 143; (b) the light chain CDR2 of SEQ ID NO: 151; and (c) the light chain CDR3 of SEQ ID NO: 163, wherein the sequences are disclosed within the specification.
Patent NZ-628904-A (NZ)
Title: Injection moulded article
Inventor: BURWELL DAMON GREGORY
IPC: A47C7/44
Filed: 2013-10-10
Abstract: An injection moulded article suitable for strain orientation is disclosed. The injection moulded article comprises: a plurality of first elongate moulded straps (533) formed in a first layer; a plurality of second elongate moulded straps (535) formed in a second layer, so that at least some of the first elongate straps (533) overlap with at least some of the second elongate straps (535); and a plurality of moulded joiner members (536) that are integrally injection moulded with the first elongate straps (533) and with the second elongate straps (535). The joiner members (536) connect between the first elongate straps (533) and the second elongate straps (535) in the regions in which the first and second elongate straps (533, 535) overlap.